General Information of the Compound
| Compound ID |
CP0274096
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-[[1-[(4-chlorophenyl)methyl]piperidin-4-yl]methoxy]-2-[2-(cyclopropanecarbonylamino)pyridin-4-yl]-N-methyl-1,3-thiazole-5-carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C27H30ClN5O3S
|
||||||||||||||||||
| Molecular Weight |
540.089
|
||||||||||||||||||
| Canonical SMILES |
CNC(=O)c1sc(nc1OCC1CCN(Cc2ccc(Cl)cc2)CC1)-c1ccnc(NC(=O)C2CC2)c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C27H30ClN5O3S/c1-29-25(35)23-26(32-27(37-23)20-8-11-30-22(14-20)31-24(34)19-4-5-19)36-16-18-9-12-33(13-10-18)15-17-2-6-21(28)7-3-17/h2-3,6-8,11,14,18-19H,4-5,9-10,12-13,15-16H2,1H3,(H,29,35)(H,30,31,34)
Show/Hide
|
||||||||||||||||||
| InChIKey |
BISZQUZMYIHDHR-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00820, Acetylcholinesterase
Protein ID: PT00962, Glycogen synthase kinase-3 beta